| Dr William Lyman Rutledge, MD | |
|
9712 W Markham St, Little Rock, AR 72205-2124 | |
| (501) 954-8800 | |
| (501) 954-8803 |
| Full Name | Dr William Lyman Rutledge |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 9712 W Markham St, Little Rock, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003820036 | NPI | - | NPPES |
| 105362001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R3422 (Arkansas) | Primary |
| Entity Name | W L Rutledge Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427297902 PECOS PAC ID: 1153478755 Enrollment ID: O20090420000107 |
News Archive
Archives of Internal Medicine: The Quality Of Care Provided To Hospitalized Patients At The End of Life - In this study, researchers used a set of quality indicators to assess the end-of-life care and pain management received by 496 patients who died three or more days after admission at the University of California-Los Angeles Medical Center. The authors found "pain assessments (94%) and treatments for pain (95%) and dyspnea [breathing problems] (87%) were performed with fidelity."
Metal elements and molecules interact in the body but visualizing them together has always been a challenge. Researchers from the RIKEN Center for Life Science Technologies in Japan have developed a new molecular imaging technology that enables them to visualize bio-metals and bio-molecules simultaneously in a live mouse.
Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere's proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.
Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Lyman Rutledge, MD Po Box 5589, Jacksonville, AR 72086-2124 Ph: (501) 661-8207 | Dr William Lyman Rutledge, MD 9712 W Markham St, Little Rock, AR 72205-2124 Ph: (501) 954-8800 |
News Archive
Archives of Internal Medicine: The Quality Of Care Provided To Hospitalized Patients At The End of Life - In this study, researchers used a set of quality indicators to assess the end-of-life care and pain management received by 496 patients who died three or more days after admission at the University of California-Los Angeles Medical Center. The authors found "pain assessments (94%) and treatments for pain (95%) and dyspnea [breathing problems] (87%) were performed with fidelity."
Metal elements and molecules interact in the body but visualizing them together has always been a challenge. Researchers from the RIKEN Center for Life Science Technologies in Japan have developed a new molecular imaging technology that enables them to visualize bio-metals and bio-molecules simultaneously in a live mouse.
Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere's proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.
Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer.
› Verified 9 days ago
Allan Dee Mckenzie, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4523 Woodlawn Dr, Little Rock, AR 72205 Phone: 501-663-2363 Fax: 501-663-2362 | |
Dr. Steven Kyser, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-5050 | |
Kasey Renea Kane, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 S Bowman Rd, Little Rock, AR 72211 Phone: 501-558-4100 | |
Dr. William Wells Burnham, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-1000 Fax: 501-257-5071 | |
Deipti H Trehun, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 530, Little Rock, AR 72205 Phone: 501-686-8000 Fax: 501-686-8421 | |
Dr. Pham Hieu Liem, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St, 748, Little Rock, AR 72205 Phone: 501-686-5944 Fax: 501-686-5884 |